Corvus Pharmaceuticals (CRVS) Depreciation and Depletion (2015 - 2017)
Corvus Pharmaceuticals' (CRVS) quarterly Depreciation and Depletion came in at $211000.0 in Q3 2017, up 32.7% year-on-year from $159000.0 in Q3 2016, and up 1.44% quarter-over-quarter from $208000.0 in Q2 2017.
Corvus Pharmaceuticals (CRVS) Depreciation and Depletion (2015 - 2017) Analysis & Trends
Corvus Pharmaceuticals' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $211000.0 for Q3 2017.
- On a quarterly basis, Depreciation and Depletion rose 32.7% year-over-year to $211000.0 in Q3 2017; TTM through Sep 2017 was $808000.0, a 73.39% increase from a year earlier, with the FY2016 full-year figure at $594000.0, up 301.35% from the prior year.
- Depreciation and Depletion advanced to $211000.0 in Q3 2017 per CRVS's latest filing, from $208000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $211000.0 in Q3 2017 and bottomed at $1000.0 in Q1 2015.
- The 3-year median for Depreciation and Depletion is $144000.0 (2016), against an average of $124090.9.
- Across the five-year window, Depreciation and Depletion jumped 10500.0% in 2016 and soared 32.7% in 2017, its largest moves.
- Year by year, Depreciation and Depletion stood at $57000.0 in 2015, then soared by 224.56% to $185000.0 in 2016, then gained by 14.05% to $211000.0 in 2017.
- Per Business Quant, the three latest CRVS Depreciation and Depletion figures stand at $211000.0 (Q3 2017), $208000.0 (Q2 2017), and $204000.0 (Q1 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 211,000.00 |
| Sep 30, 2017 | 211,000.00 |
| Jun 30, 2017 | 208,000.00 |
| Jun 30, 2017 | 208,000.00 |
| Mar 31, 2017 | 204,000.00 |
| Mar 31, 2017 | 204,000.00 |
| Dec 31, 2016 | 185,000.00 |
| Dec 31, 2016 | 185,000.00 |
| Sep 30, 2016 | 159,000.00 |
| Sep 30, 2016 | 159,000.00 |
| Jun 30, 2016 | 144,000.00 |
| Jun 30, 2016 | 144,000.00 |
| Mar 31, 2016 | 106,000.00 |
| Mar 31, 2016 | 106,000.00 |
| Dec 31, 2015 | 57,000.00 |
| Dec 31, 2015 | 57,000.00 |
| Sep 30, 2015 | 55,000.00 |
| Sep 30, 2015 | 55,000.00 |
| Jun 30, 2015 | 35,000.00 |
| Jun 30, 2015 | 35,000.00 |